An interventional study of Oxygen in Oxygen Therapy, sponsored by Aswan University Hospital. Completed at 1 site in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-04-30.
Sponsored by Aswan University Hospital · Not applicable, Interventional, and Treatment
To assess the benefits and drawbacks of high versus low oxygen therapy on mortality and myocardial function in mechanically ventilated patients
Aswan University Hospital is the lead sponsor of 95 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Inclusion Criteria:
Exclusion Criteria:
* Spo2 alarm limit will be set as follow: - upper limit 94% and lower limit 88% * If spo2 \>94% Unless fio2 is 0.21%, decrease fio2 by 0.10% at intervals no longer than 5 minutes till spo2 = 94% * If spo2 within target Decrease fio2 0.05% at intervals no longer than 30 min till fio2 0.21% reached or spo2 = 88 % * If spo2 \< 88 % return to previous spo2 that achieve target spo2. * if an arterial blood gas demonstrate that the PaO2 is \< 60 mmHg FiO2 will increased if clinically appropriate irrespective of the SpO2 reading ( target po2 60-100 mmhg ) * During intubation, airway suction, tracheostomy, bronchoscopy, transportation outside of the ICU for radiological or other investigations or for procedures or operations, other critical situations such as hemodynamic collapse, patients will receive standard (non-study)treatment. * Echocardiography on randomization and at end of the study: we will calculate stroke volume according to Simpson's apical four view
Drug: Oxygen
* Spo2 target \> 95% * No specific measures will be taken to avoid high fio2 or high po2 * Use of upper alarm limit for spo2 will be prohibited * Echocardiography on randomization and at end of the study: we will calculate stroke volume according to Simpson's apical four view
Drug: Oxygen
* Decreasing fraction of inspired oxygen and its effect on mortality and myocardial function * administered by invasive mechanical ventilation with fraction of inspired oxygen between 0.21 and 1
Change in Stroke volume in milliliters
Volume of blood in milliliters that is ejected from heart each second and measured By Echocardiography
Time frame: Change from Baseline stroke volume At ICU admission and through study completion An average 6 months
Change in ejection fraction of heart in percentage
percentage of blood that's pumped out of a filled ventricle with each heartbeat And measured by echocardiography
Time frame: Change from baseline ejection fraction at icu admission and through study completion An Average 6 months
Acute respiratory distress syndrome
Acute persistent hypoxia with bilateral lung infiltrate due to non cardiac cause
Time frame: From icu admission date to icu discharge date an average of 2 weeks
Sepsis
Systolic blood pressure \< 90 Respiratory rate \> 22 Heart rate \> 100
Time frame: From icu admission date to icu discharge date an average of 2 weeks
Stroke
Cerebrovascular accidents
Time frame: From icu admission date to icu discharge date an average of 2 weeks
Mechanical Ventilator free days
Days without mechanical ventilation
Time frame: From icu admission date to icu discharge date an average of 2 weeks
Shock
Systolic blood pressure \< 90 mmHg
Time frame: From icu admission date to icu discharge date an average of 2 weeks
Surgery revision
Surgical re exploration
Time frame: From icu admission date to icu discharge date an average of 2 weeks
Vasopressor
Use of vasopressors as norepinephrine and epinephrine
Time frame: From icu admission date to icu discharge date an average of 2 weeks
ICU stay
Duration of intensive care stay
Time frame: From icu admission date to icu discharge date an average of 2 weeks
Hospital stay
Duration of hospital stay
Time frame: From icu admission date to icu discharge date an average of 2 weeks
Mortality
Death of patient
Time frame: From icu admission date to icu discharge date an average of 2 weeks
Plan to share: Yes
No publications or documents are linked to this record.
This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Aswan University Hospital